To The Moon
Home
News
TigerAI
Log In
Sign Up
NeM0ooo
+Follow
Posts · 108
Posts · 108
Following · 0
Following · 0
Followers · 0
Followers · 0
NeM0ooo
NeM0ooo
·
2022-01-24
Like
Buy These 3 Potential 10X Stocks Now, and You Might Look Like a Genius Later
There's chaos in growth land and opportunities for the bold.
Buy These 3 Potential 10X Stocks Now, and You Might Look Like a Genius Later
看
4.17K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-22
[Spurting]
Sorry, this post has been deleted
看
3.46K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-21
Like
Sorry, this post has been deleted
看
4.57K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-20
Like
US STOCKS-Wall Street Sell-Off Deepens, Nasdaq Confirms Correction
* Nasdaq now down 10.7% from Nov 19 record close* BofA, Morgan Stanley wrap up bank earnings on upbe
US STOCKS-Wall Street Sell-Off Deepens, Nasdaq Confirms Correction
看
3.26K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-17
Like
Sorry, this post has been deleted
看
4.46K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-17
Like
Sorry, this post has been deleted
看
5.11K
回复
Comment
点赞
4
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-15
Like
Morgan Stanley Promotes Biggest Class of Managing Directors Since 2012
While efforts to hire and retain workers pick up across Wall Street, Morgan Stanley(NYSE:MS)names 19
Morgan Stanley Promotes Biggest Class of Managing Directors Since 2012
看
4.69K
回复
Comment
点赞
4
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-14
Like
J&J booster 85% effective against hospitalisation by Omicron for 1-2 months -S.African study
JOHANNESBURG, Jan 14 (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effectiv
J&J booster 85% effective against hospitalisation by Omicron for 1-2 months -S.African study
看
4.71K
回复
Comment
点赞
1
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-13
Like
Novavax Stock Still Has A Solid Chance
The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot pick
Novavax Stock Still Has A Solid Chance
看
3.03K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-12
Like
Sorry, this post has been deleted
看
3.40K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
Load more
Most Discussed
{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4091976027440070","uuid":"4091976027440070","gmtCreate":1628872964574,"gmtModify":1629964817147,"name":"NeM0ooo","pinyin":"nem0ooo","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":10,"headSize":271,"tweetSize":108,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9007445601,"gmtCreate":1642991056019,"gmtModify":1676533762891,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091976027440070","authorIdStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007445601","repostId":"2205027095","repostType":4,"repost":{"id":"2205027095","kind":"highlight","pubTimestamp":1642990222,"share":"https://ttm.financial/m/news/2205027095?lang=en_US&edition=fundamental","pubTime":"2022-01-24 10:10","market":"us","language":"en","title":"Buy These 3 Potential 10X Stocks Now, and You Might Look Like a Genius Later","url":"https://stock-news.laohu8.com/highlight/detail?id=2205027095","media":"Motley Fool","summary":"There's chaos in growth land and opportunities for the bold.","content":"<div>\n<p>Life as a growth stock investor hasn't been very much fun lately. Inflation and the eventual rise in interest rates continue to push against many small and mid-cap growth stocks, which are reaching ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/23/buy-these-3-potential-10x-stocks-now-look-like-a-g/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy These 3 Potential 10X Stocks Now, and You Might Look Like a Genius Later</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy These 3 Potential 10X Stocks Now, and You Might Look Like a Genius Later\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-24 10:10 GMT+8 <a href=https://www.fool.com/investing/2022/01/23/buy-these-3-potential-10x-stocks-now-look-like-a-g/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Life as a growth stock investor hasn't been very much fun lately. Inflation and the eventual rise in interest rates continue to push against many small and mid-cap growth stocks, which are reaching ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/23/buy-these-3-potential-10x-stocks-now-look-like-a-g/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4561":"索罗斯持仓","FVRR":"Fiverr International Ltd.","BK4539":"次新股","GLBE":"Global-E Online Ltd.","BK4023":"应用软件","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓","BK4106":"数据处理与外包服务","BK4503":"景林资产持仓","API":"声网","BK4122":"互联网与直销零售","IPO":"Renaissance IPO ETF","MQ":"Marqeta, Inc."},"source_url":"https://www.fool.com/investing/2022/01/23/buy-these-3-potential-10x-stocks-now-look-like-a-g/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2205027095","content_text":"Life as a growth stock investor hasn't been very much fun lately. Inflation and the eventual rise in interest rates continue to push against many small and mid-cap growth stocks, which are reaching new lows week after week.But there's an argument to be made that the kitchen sink that investors are throwing out might have some gems in it. That's right: There are stocks with the long-term potential to grow tenfold hiding in plain sight. Consider buying these three stocks now, and you might look like a genius later on.Image source: Getty Images.1. Fiverr InternationalAccording to research by Upwork, more than 50% of the U.S. population could participate in freelancing by 2027, making it a permanent staple in the economy instead of a pandemic fluke. Fiverr International (NYSE:FVRR) operates a marketplace platform where freelancers and buyers do business.Fiverr benefited from the lockdowns in 2020 as people leaned more heavily on online businesses and freelancing to make ends meet. The company's revenue grew 77% year over year in 2020, an uptick from the 42% increase in 2019. However, the stock price ran ahead of its growth, pushing its price-to-sales (P/S) ratio skyward, going as high as 56 in early 2021.FVRR PS Ratio data by YChartsThe sell-off in growth stocks also impacted Fiverr, bringing the stock's P/S back down to pre-lockdown levels at less than 11. Meanwhile, revenue growth remains solid following its pandemic surge; analysts expect the 2021 fiscal year to end with revenue up 55% year over year, and 2022 revenue estimates call for 26% growth. I think the long-term development of freelancing could give Fiverr an opportunity to continue its upward trajectory for years, and the stock's $3 billion market cap is still tiny compared to its potential upside.2. MarqetaInnovative companies like Uber for ride-hailing, DoorDash for food delivery, and Block for digital banking have changed life for the consumer over the past decade. However, all of these companies need unique solutions for handling payments and moving money. Payments technology company Marqeta (NASDAQ:MQ) enables companies, including some of its customers listed above, to build and customize payment solutions through its software application programming interface (API).Marqeta is like a middleman between these new payment applications and the existing payment networks of the financial system such as Visa and Mastercard. Marqeta helps these two sides work together. It went public via an initial public offering (IPO) in June 2021, and its stock now trades below its IPO price due to the marketwide chaos.MQ PS Ratio data by YChartsThe stock's P/S ratio has fallen from more than 40 to a much more reasonable 12 in just over six months. The company is thriving, posting 56% year-over-year revenue growth in its 2021 third quarter. The company's biggest customer is Block, which accounts for more than 70% of revenue, but it serves many companies in the surging buy now, pay later industry, which could help drive growth. The stock's market cap is a measly $7 billion in the massive payments industry, so I like the long-term potential.3. Global-E OnlineE-commerce isn't a new investing theme; Amazon has grown like a weed for the past 20 years. But e-commerce has remained very isolated, meaning that it's tough for someone in one country to shop online in another. Global-E Online's (NASDAQ:GLBE) platform helps enable direct-to-consumer cross-border e-commerce. Its platform localizes language, pricing, taxes, and logistics to make the shopping experience smoother for shoppers.Shopify bought 5% stake in the company, using its platform for cross-border transactions. Global-E has also partnered with Meta Platforms; these deep-pocketed companies have chosen to outsource cross-border commerce to Global-E instead of trying to compete with them, which I think speaks to the product. Its net revenue retention rate is 140%, signaling that Global-E's customers spend more once they join.GLBE PS Ratio data by YChartsThe company just went public in mid-2021, so it's another young business that needs to prove itself over time. However, analysts expect $240 million in revenue for the entire 2021 year, and 53% revenue growth in 2022, against a total addressable market that management estimates is worth $736 billion. At a market cap of just under $6 billion, Global-E's story could just be getting started.","news_type":1,"symbols_score_info":{"GLBE":1,"MQ":1,"API":1,"IPO":1,"FVRR":1}},"isVote":1,"tweetType":1,"viewCount":4168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007600222,"gmtCreate":1642850964033,"gmtModify":1676533752746,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091976027440070","authorIdStr":"4091976027440070"},"themes":[],"htmlText":"[Spurting] ","listText":"[Spurting] ","text":"[Spurting]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007600222","repostId":"2205042784","repostType":4,"isVote":1,"tweetType":1,"viewCount":3457,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007302944,"gmtCreate":1642762186624,"gmtModify":1676533743795,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091976027440070","authorIdStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007302944","repostId":"1152667345","repostType":4,"isVote":1,"tweetType":1,"viewCount":4571,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004469290,"gmtCreate":1642663143859,"gmtModify":1676533733433,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091976027440070","authorIdStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004469290","repostId":"2204320050","repostType":4,"repost":{"id":"2204320050","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642629300,"share":"https://ttm.financial/m/news/2204320050?lang=en_US&edition=fundamental","pubTime":"2022-01-20 05:55","market":"us","language":"en","title":"US STOCKS-Wall Street Sell-Off Deepens, Nasdaq Confirms Correction","url":"https://stock-news.laohu8.com/highlight/detail?id=2204320050","media":"Reuters","summary":"* Nasdaq now down 10.7% from Nov 19 record close* BofA, Morgan Stanley wrap up bank earnings on upbe","content":"<html><head></head><body><p>* Nasdaq now down 10.7% from Nov 19 record close</p><p>* BofA, <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> wrap up bank earnings on upbeat note</p><p>* Procter & Gamble gains after raising outlook</p><p>* Indexes down: Dow 0.96%, S&P 0.97%, Nasdaq 1.15%</p><p>Jan 19 (Reuters) - Wall Street's main indexes ended sharply lower on Wednesday, with the tech-heavy Nasdaq confirming it was in a correction, after a diverse set of corporate earnings and as investors continued to worry about higher U.S. Treasury yields and the Federal Reserve tightening monetary policy.</p><p>The Nasdaq ended down 10.7% from its Nov. 19 closing record high, as stocks sold off into the market close. A correction is confirmed when an index closes 10% or more below its record closing level.</p><p>The Nasdaq's last correction was in early 2021, when the tech-heavy index fell more than 10% from Feb. 12 to March 8. It was the fourth time in the two years</p><p>since the coronavirus pandemic shook global markets that the index has found itself in a correction.</p><p>On Wednesday, Apple shares fell 2.1%, weighing most on the Nasdaq, while declines in Tesla and Amazon also dragged on the index.</p><p>Stocks have gotten off to a rocky start in 2022, as a fast rise in Treasury yields amid concerns the Fed will become aggressive in controlling inflation has particularly hit tech and growth shares. The benchmark S&P 500 is down about 5% so far this year.</p><p>“Any beginning of tightening often results in significant volatility and I think there is always that risk that there is a policy error and it ends the economic cycle," said Kristina Hooper, chief global market strategist at Invesco. "So we just have a lot of apprehension.”</p><p>The Dow Jones Industrial Average fell 339.82 points, or 0.96%, to 35,028.65, the S&P 500 lost 44.35 points, or 0.97%, to 4,532.76 and the Nasdaq Composite dropped 166.64 points, or 1.15%, to 14,340.26.</p><p>Consumer discretionary fell most among S&P 500 sectors, dropping 1.8%, while financials dropped about 1.7% and technology slid 1.4%.</p><p>The small-cap Russell 2000 fell 1.6%.</p><p>Stocks had tumbled on Tuesday, with the Nasdaq falling 2.6%, after weak results from Goldman Sachs and a spike in Treasury yields. U.S. Treasury yields eased on Wednesday from two-year highs.</p><p>Investors are looking to next week's Fed policy meeting for more clarity on central bankers' plans to rein in inflation. Data last week showed U.S. consumer prices increased solidly in December, culminating in the largest annual rise in inflation in nearly four decades.</p><p>"There's a fair amount of anxiety in terms of how the next three to six months are going to play out with a rate-hike cycle set to start likely in March," said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles.</p><p>In company news, shares of Procter & Gamble rose 3.4% after the consumer goods company bumped up its annual sales forecast.</p><p>$Bank of America Corp(BAC-N)$ reported a better-than-expected 30% jump in quarterly profit, while Morgan Stanley also reported fourth-quarter profit which beat market expectations, following uneven results from other banks. Bank of America shares rose 0.4%, while Morgan Stanley shares gained 1.8%.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.09-to-1 ratio favored decliners.</p><p>The S&P 500 posted 13 new 52-week highs and seven new lows; the Nasdaq Composite recorded 23 new highs and 630 new lows.</p><p>About 11.4 billion shares changed hands in U.S. exchanges, compared with the 10 billion daily average over the last 20 sessions.</p><p>Nasdaq confirms fourth correction since pandemic hit.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Wall Street Sell-Off Deepens, Nasdaq Confirms Correction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Wall Street Sell-Off Deepens, Nasdaq Confirms Correction\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-20 05:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>* Nasdaq now down 10.7% from Nov 19 record close</p><p>* BofA, <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> wrap up bank earnings on upbeat note</p><p>* Procter & Gamble gains after raising outlook</p><p>* Indexes down: Dow 0.96%, S&P 0.97%, Nasdaq 1.15%</p><p>Jan 19 (Reuters) - Wall Street's main indexes ended sharply lower on Wednesday, with the tech-heavy Nasdaq confirming it was in a correction, after a diverse set of corporate earnings and as investors continued to worry about higher U.S. Treasury yields and the Federal Reserve tightening monetary policy.</p><p>The Nasdaq ended down 10.7% from its Nov. 19 closing record high, as stocks sold off into the market close. A correction is confirmed when an index closes 10% or more below its record closing level.</p><p>The Nasdaq's last correction was in early 2021, when the tech-heavy index fell more than 10% from Feb. 12 to March 8. It was the fourth time in the two years</p><p>since the coronavirus pandemic shook global markets that the index has found itself in a correction.</p><p>On Wednesday, Apple shares fell 2.1%, weighing most on the Nasdaq, while declines in Tesla and Amazon also dragged on the index.</p><p>Stocks have gotten off to a rocky start in 2022, as a fast rise in Treasury yields amid concerns the Fed will become aggressive in controlling inflation has particularly hit tech and growth shares. The benchmark S&P 500 is down about 5% so far this year.</p><p>“Any beginning of tightening often results in significant volatility and I think there is always that risk that there is a policy error and it ends the economic cycle," said Kristina Hooper, chief global market strategist at Invesco. "So we just have a lot of apprehension.”</p><p>The Dow Jones Industrial Average fell 339.82 points, or 0.96%, to 35,028.65, the S&P 500 lost 44.35 points, or 0.97%, to 4,532.76 and the Nasdaq Composite dropped 166.64 points, or 1.15%, to 14,340.26.</p><p>Consumer discretionary fell most among S&P 500 sectors, dropping 1.8%, while financials dropped about 1.7% and technology slid 1.4%.</p><p>The small-cap Russell 2000 fell 1.6%.</p><p>Stocks had tumbled on Tuesday, with the Nasdaq falling 2.6%, after weak results from Goldman Sachs and a spike in Treasury yields. U.S. Treasury yields eased on Wednesday from two-year highs.</p><p>Investors are looking to next week's Fed policy meeting for more clarity on central bankers' plans to rein in inflation. Data last week showed U.S. consumer prices increased solidly in December, culminating in the largest annual rise in inflation in nearly four decades.</p><p>"There's a fair amount of anxiety in terms of how the next three to six months are going to play out with a rate-hike cycle set to start likely in March," said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles.</p><p>In company news, shares of Procter & Gamble rose 3.4% after the consumer goods company bumped up its annual sales forecast.</p><p>$Bank of America Corp(BAC-N)$ reported a better-than-expected 30% jump in quarterly profit, while Morgan Stanley also reported fourth-quarter profit which beat market expectations, following uneven results from other banks. Bank of America shares rose 0.4%, while Morgan Stanley shares gained 1.8%.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.09-to-1 ratio favored decliners.</p><p>The S&P 500 posted 13 new 52-week highs and seven new lows; the Nasdaq Composite recorded 23 new highs and 630 new lows.</p><p>About 11.4 billion shares changed hands in U.S. exchanges, compared with the 10 billion daily average over the last 20 sessions.</p><p>Nasdaq confirms fourth correction since pandemic hit.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2204320050","content_text":"* Nasdaq now down 10.7% from Nov 19 record close* BofA, Morgan Stanley wrap up bank earnings on upbeat note* Procter & Gamble gains after raising outlook* Indexes down: Dow 0.96%, S&P 0.97%, Nasdaq 1.15%Jan 19 (Reuters) - Wall Street's main indexes ended sharply lower on Wednesday, with the tech-heavy Nasdaq confirming it was in a correction, after a diverse set of corporate earnings and as investors continued to worry about higher U.S. Treasury yields and the Federal Reserve tightening monetary policy.The Nasdaq ended down 10.7% from its Nov. 19 closing record high, as stocks sold off into the market close. A correction is confirmed when an index closes 10% or more below its record closing level.The Nasdaq's last correction was in early 2021, when the tech-heavy index fell more than 10% from Feb. 12 to March 8. It was the fourth time in the two yearssince the coronavirus pandemic shook global markets that the index has found itself in a correction.On Wednesday, Apple shares fell 2.1%, weighing most on the Nasdaq, while declines in Tesla and Amazon also dragged on the index.Stocks have gotten off to a rocky start in 2022, as a fast rise in Treasury yields amid concerns the Fed will become aggressive in controlling inflation has particularly hit tech and growth shares. The benchmark S&P 500 is down about 5% so far this year.“Any beginning of tightening often results in significant volatility and I think there is always that risk that there is a policy error and it ends the economic cycle,\" said Kristina Hooper, chief global market strategist at Invesco. \"So we just have a lot of apprehension.”The Dow Jones Industrial Average fell 339.82 points, or 0.96%, to 35,028.65, the S&P 500 lost 44.35 points, or 0.97%, to 4,532.76 and the Nasdaq Composite dropped 166.64 points, or 1.15%, to 14,340.26.Consumer discretionary fell most among S&P 500 sectors, dropping 1.8%, while financials dropped about 1.7% and technology slid 1.4%.The small-cap Russell 2000 fell 1.6%.Stocks had tumbled on Tuesday, with the Nasdaq falling 2.6%, after weak results from Goldman Sachs and a spike in Treasury yields. U.S. Treasury yields eased on Wednesday from two-year highs.Investors are looking to next week's Fed policy meeting for more clarity on central bankers' plans to rein in inflation. Data last week showed U.S. consumer prices increased solidly in December, culminating in the largest annual rise in inflation in nearly four decades.\"There's a fair amount of anxiety in terms of how the next three to six months are going to play out with a rate-hike cycle set to start likely in March,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles.In company news, shares of Procter & Gamble rose 3.4% after the consumer goods company bumped up its annual sales forecast.$Bank of America Corp(BAC-N)$ reported a better-than-expected 30% jump in quarterly profit, while Morgan Stanley also reported fourth-quarter profit which beat market expectations, following uneven results from other banks. Bank of America shares rose 0.4%, while Morgan Stanley shares gained 1.8%.Declining issues outnumbered advancing ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.09-to-1 ratio favored decliners.The S&P 500 posted 13 new 52-week highs and seven new lows; the Nasdaq Composite recorded 23 new highs and 630 new lows.About 11.4 billion shares changed hands in U.S. exchanges, compared with the 10 billion daily average over the last 20 sessions.Nasdaq confirms fourth correction since pandemic hit.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,"NQmain":1,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":3263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005484481,"gmtCreate":1642382337230,"gmtModify":1676533706157,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091976027440070","authorIdStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005484481","repostId":"1102620537","repostType":4,"isVote":1,"tweetType":1,"viewCount":4460,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005485540,"gmtCreate":1642382257536,"gmtModify":1676533706140,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091976027440070","authorIdStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005485540","repostId":"1102620537","repostType":4,"isVote":1,"tweetType":1,"viewCount":5110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005859416,"gmtCreate":1642248302260,"gmtModify":1676533695592,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091976027440070","authorIdStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005859416","repostId":"1167122618","repostType":4,"repost":{"id":"1167122618","kind":"news","pubTimestamp":1642212214,"share":"https://ttm.financial/m/news/1167122618?lang=en_US&edition=fundamental","pubTime":"2022-01-15 10:03","market":"us","language":"en","title":"Morgan Stanley Promotes Biggest Class of Managing Directors Since 2012","url":"https://stock-news.laohu8.com/highlight/detail?id=1167122618","media":"Seeking Alpha","summary":"While efforts to hire and retain workers pick up across Wall Street, Morgan Stanley(NYSE:MS)names 19","content":"<html><head></head><body><ul><li>While efforts to hire and retain workers pick up across Wall Street, Morgan Stanley(NYSE:MS)names 199 employees as new managing directors, a person with knowledge on the matter told Bloomberg.</li><li>This is up from 171 last year and 130 in 2020, Bloomberg reports. The U.S. region counts for 64% of the promotions, with 23% in Europe, the Middle East and Africa, and 14% in Asia.</li><li>A third of the new managing directors are women, the person told Bloomberg. This means 23% of the bank's managing directors are female, a new record, Bloomberg notes.</li><li>Recall Goldman Sachs(NYSE:GS)recently said it plans to boost hiring in Latin America after a record year.</li><li>Previously, (Jan. 4, 2021) Morgan Stanley inked a lease for BlackRock'sheadquarters in New York City.</li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley Promotes Biggest Class of Managing Directors Since 2012</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley Promotes Biggest Class of Managing Directors Since 2012\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-15 10:03 GMT+8 <a href=https://seekingalpha.com/news/3788415-morgan-stanley-promotes-most-staff-to-managing-directors-since-2012-bloomberg><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While efforts to hire and retain workers pick up across Wall Street, Morgan Stanley(NYSE:MS)names 199 employees as new managing directors, a person with knowledge on the matter told Bloomberg.This is ...</p>\n\n<a href=\"https://seekingalpha.com/news/3788415-morgan-stanley-promotes-most-staff-to-managing-directors-since-2012-bloomberg\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MS":"摩根士丹利"},"source_url":"https://seekingalpha.com/news/3788415-morgan-stanley-promotes-most-staff-to-managing-directors-since-2012-bloomberg","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167122618","content_text":"While efforts to hire and retain workers pick up across Wall Street, Morgan Stanley(NYSE:MS)names 199 employees as new managing directors, a person with knowledge on the matter told Bloomberg.This is up from 171 last year and 130 in 2020, Bloomberg reports. The U.S. region counts for 64% of the promotions, with 23% in Europe, the Middle East and Africa, and 14% in Asia.A third of the new managing directors are women, the person told Bloomberg. This means 23% of the bank's managing directors are female, a new record, Bloomberg notes.Recall Goldman Sachs(NYSE:GS)recently said it plans to boost hiring in Latin America after a record year.Previously, (Jan. 4, 2021) Morgan Stanley inked a lease for BlackRock'sheadquarters in New York City.","news_type":1,"symbols_score_info":{"MS":0.9}},"isVote":1,"tweetType":1,"viewCount":4690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005950385,"gmtCreate":1642152555619,"gmtModify":1676533686923,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091976027440070","authorIdStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005950385","repostId":"1194577805","repostType":4,"repost":{"id":"1194577805","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642151423,"share":"https://ttm.financial/m/news/1194577805?lang=en_US&edition=fundamental","pubTime":"2022-01-14 17:10","market":"us","language":"en","title":"J&J booster 85% effective against hospitalisation by Omicron for 1-2 months -S.African study","url":"https://stock-news.laohu8.com/highlight/detail?id=1194577805","media":"Reuters","summary":"JOHANNESBURG, Jan 14 (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effectiv","content":"<html><head></head><body><p>JOHANNESBURG, Jan 14 (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is received, the head of South Africa's Medical Research Council (SAMRC) said on Friday.</p><p>Glenda Grey presented the findings of a SAMRC study at a South African health ministry briefing on the COVID-19 fourth wave, which has been driven by the new variant.</p><p>"We saw an 85% vaccine effectiveness and we saw that this kind of vaccine effectiveness is maintained for up to two months," she said. We are very happy to report very high levels of vaccine effectiveness against Omicron."</p><p>The study looked at hospitalisations of healthcare workers infected with during the fourth wave, and found that the booster shot reduced hospitalisations by 63% in the first two weeks after the booster, going up to 85% after that for between one and two months.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J booster 85% effective against hospitalisation by Omicron for 1-2 months -S.African study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J booster 85% effective against hospitalisation by Omicron for 1-2 months -S.African study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-14 17:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>JOHANNESBURG, Jan 14 (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is received, the head of South Africa's Medical Research Council (SAMRC) said on Friday.</p><p>Glenda Grey presented the findings of a SAMRC study at a South African health ministry briefing on the COVID-19 fourth wave, which has been driven by the new variant.</p><p>"We saw an 85% vaccine effectiveness and we saw that this kind of vaccine effectiveness is maintained for up to two months," she said. We are very happy to report very high levels of vaccine effectiveness against Omicron."</p><p>The study looked at hospitalisations of healthcare workers infected with during the fourth wave, and found that the booster shot reduced hospitalisations by 63% in the first two weeks after the booster, going up to 85% after that for between one and two months.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194577805","content_text":"JOHANNESBURG, Jan 14 (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is received, the head of South Africa's Medical Research Council (SAMRC) said on Friday.Glenda Grey presented the findings of a SAMRC study at a South African health ministry briefing on the COVID-19 fourth wave, which has been driven by the new variant.\"We saw an 85% vaccine effectiveness and we saw that this kind of vaccine effectiveness is maintained for up to two months,\" she said. We are very happy to report very high levels of vaccine effectiveness against Omicron.\"The study looked at hospitalisations of healthcare workers infected with during the fourth wave, and found that the booster shot reduced hospitalisations by 63% in the first two weeks after the booster, going up to 85% after that for between one and two months.","news_type":1,"symbols_score_info":{"JNJ":0.9}},"isVote":1,"tweetType":1,"viewCount":4708,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002579368,"gmtCreate":1642052222545,"gmtModify":1676533676288,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091976027440070","authorIdStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002579368","repostId":"1144288118","repostType":4,"repost":{"id":"1144288118","kind":"news","pubTimestamp":1642051328,"share":"https://ttm.financial/m/news/1144288118?lang=en_US&edition=fundamental","pubTime":"2022-01-13 13:22","market":"us","language":"en","title":"Novavax Stock Still Has A Solid Chance","url":"https://stock-news.laohu8.com/highlight/detail?id=1144288118","media":"InvestorPlace","summary":"The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot pick","content":"<div>\n<p>The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot picks today. Although Novavax(NASDAQ:NVAX) hasn’t had a smooth ride lately, there is a lot to look ...</p>\n\n<a href=\"https://investorplace.com/2022/01/nvax-stock-still-has-a-solid-chance-at-being-a-vaccine-race-winner/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Stock Still Has A Solid Chance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Stock Still Has A Solid Chance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-13 13:22 GMT+8 <a href=https://investorplace.com/2022/01/nvax-stock-still-has-a-solid-chance-at-being-a-vaccine-race-winner/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot picks today. Although Novavax(NASDAQ:NVAX) hasn’t had a smooth ride lately, there is a lot to look ...</p>\n\n<a href=\"https://investorplace.com/2022/01/nvax-stock-still-has-a-solid-chance-at-being-a-vaccine-race-winner/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://investorplace.com/2022/01/nvax-stock-still-has-a-solid-chance-at-being-a-vaccine-race-winner/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144288118","content_text":"The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot picks today. Although Novavax(NASDAQ:NVAX) hasn’t had a smooth ride lately, there is a lot to look forward to. Investors tend to think that the current surge in Covid-19 cases across the globe could mean an end of the pandemic shortly but this may not be the case. Despite the dip in NVAX stock in 2021, it could have a stellar 2022.The stock has dipped significantly over the past six months and is currently trading much lower than its all-time high. There haven’t been any major company announcements or significant events that could’ve led to this decline in the price. Therefore, it stems from investors’ lack of enthusiasm towards the company’s prospects.This might change in 2022. NVAX stock is trading at $130 and could inch closer to $150 soon.Here are two reasons I think the stock will move upwards.Vaccine Demand Could ExplodeDespite the rise in coronavirus cases across the globe, the cases are milder and the hospitalization rates are lower. The good news is that it could lead to lower deaths and a higher recovery rate.However, this does not change the vaccine scenario. The demand for vaccines is not going to decline anytime soon and if the current surge continues, we could see a rise in demand.Once an early favorite, Novavax took too long to file for Emergency Use Authorization (EUA) in the U.S. due to manufacturing and technical issues. This in turn led to the consistent dip in the stock throughout 2021.Since the Food and Drug Administration (FDA) allows the mixing of vaccines, there will still be a demand for Novavax as a booster. It could give a huge lift to the company and will allow it to gain a larger market share.The demand for vaccines will be a key factor for the company. If it can meet the demands by increasing the manufacturing capacity, it will be able to generate massive revenue.On these metrics alone, NVAX stock could be a winner this year.It is also important to keep in mind that the company only recently got authorizations from different countries and this will reflect in the bottom line for the next quarter.Novavax Is Getting Approvals From Different CountriesNovavax already has authorization in 31 countries and this is no small feat.The company is working towards supplying more than200 million doses to EU countries alone. They expect a European Union EUA for their vaccine in the next few months which could take the stock higher.Thanks to these international authorizations, Novavax does not depend on any single country, like the United States, for revenue. It can manage to generate solid revenue by providing vaccines to developing countries and the European Union. The first-quarter numbers will be important for the investors as they will speak about the production capacity and the deliveries of the vaccine.Novavax’s vaccine data is positive. And if it manages to roll out the vaccines on time, NVAX stock will go even higher.The Bottom Line On NVAX StockThe next quarter for the company could be huge and it could start generating strong revenue very soon.There is always a risk when a stock is heavily dependant on a single product but if the company manages to move at the right time and gets the authorization, it could beat analyst projections.NVAX stock is trading at a discount currently and the coming quarter could take it to a new high.If the pandemic becomes endemic in the near future, we will regularly need vaccines and this is when Novavax will finally be a winner in the vaccine race.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3030,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002860341,"gmtCreate":1641963911091,"gmtModify":1676533667250,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091976027440070","authorIdStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002860341","repostId":"2202735009","repostType":4,"isVote":1,"tweetType":1,"viewCount":3401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}